Angiogenesis is an independent prognostic factor in malignant mesothelioma.
about
Biomarkers and prognostic factors for mesotheliomaCharacterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasisSpotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to dateInvestigational approaches for mesothelioma.Intra-tumoural microvessel density in human solid tumours.The role of interleukin-6 in malignant mesotheliomaMalignant pleural mesothelioma--an update.Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.Expression of cancer-associated molecules in malignant mesotheliomaBiomarkers for malignant pleural mesothelioma: current status.New diagnostic and molecular characteristics of malignant mesothelioma.Malignant pleural mesothelioma: current treatments and emerging drugs.Translational therapies for malignant pleural mesothelioma.Review on clinical trials of targeted treatments in malignant mesothelioma.Systemic treatment of malignant pleural mesothelioma.Anti-angiogenic therapies for malignant pleural mesothelioma.Malignant pleural mesothelioma: from the bench to the bedside.Therapies currently in Phase II trials for malignant pleural mesothelioma.Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura.Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma.SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.Clinical and biologic prognostic factors in malignant pleural mesothelioma.Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis.Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesotheliomaComparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins
P2860
Q28387194-0A20EDB7-01E5-4B7F-957B-D49A279C8B35Q33243641-20CB8F45-C182-4A92-9148-807299C4192FQ33563281-D590AE3F-4240-4570-A409-25C5FB94B577Q34293068-4016755F-215C-4E3C-8152-F7576BB2FF41Q34708258-E362AB69-ED0C-42E5-B4D6-F754DF056FECQ35200628-710A3FD8-CC97-496E-BEEF-49899B86CE61Q35740408-96B32695-D34E-48A2-89C7-F697531E7A21Q36337646-E4E1119C-2BDB-401A-BF07-EEB461F22010Q37240065-3A9F59CF-74FE-4124-A1C0-E664FBB17C29Q37281015-1D1FE6B6-A204-4883-B6D0-0CF8A2AE914EQ37335377-5F786EC5-EED7-4B75-8B39-79277EFD1D67Q37360580-3C6030D8-2266-4D8C-BFD5-F47821ECCD04Q37529848-0B9B0E24-94BD-4DE3-B98A-8A153714DC9DQ37734455-99B9866C-9E03-4CB7-BFF9-B061425D27EBQ37873380-AA3B8FB0-7513-4BED-9426-10680FF34E51Q37992694-5453F0BB-6A77-4458-9B13-A97B864E1376Q38004067-45BE43A0-00E9-45D9-8DC4-E422F944ABD6Q38019747-56C9AA48-F87D-4EF0-A536-58D962A86AA8Q38118385-CFF5B140-8792-42CF-8DBD-2FD2F983DAAFQ38308730-9EE6AB9E-FD65-43A7-A284-2DCF0E55941AQ38815319-F96F1262-1603-46D2-8C7A-555F87AD6987Q39350876-003C3B99-92AB-4E5A-9BAA-AD28B20C2BC6Q50050310-B66F7557-E509-43F4-A741-CCCEFCA54D08Q51501402-BEB27B90-226A-425B-8985-F03784A58C7CQ51731968-F799C74F-0828-4E7D-928A-0E97B9737BD4Q53248796-0F5B2C7A-4AE2-4FDC-B5B8-DA9FB12F9E20Q54691246-AF6C0ADE-C8FD-4FF2-9199-6BAE0D7BBE9AQ57071216-A21BAAEC-589A-4BB0-93B8-6A17F4037964Q59033566-E5F4D293-BC2B-460C-BACD-0915CD2195CE
P2860
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@ast
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@en
type
label
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@ast
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@en
prefLabel
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@ast
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@en
P2093
P2860
P356
P1476
Angiogenesis is an independent prognostic factor in malignant mesothelioma.
@en
P2093
Edwards JG
O'Byrne KJ
P2860
P2888
P304
P356
10.1054/BJOC.2001.1997
P407
P577
2001-09-01T00:00:00Z
P5875
P6179
1009987338